Predictive Oncology Inc. - Common Stock (POAI)

Predictive Oncology Inc is a healthcare technology company focused on advancing personalized medicine through the use of artificial intelligence and machine learning

The company leverages a proprietary platform to analyze and model cancer treatment responses, aiming to provide insights that optimize therapeutic strategies for individual patients. By integrating extensive genomic and clinical data, Predictive Oncology seeks to improve patient outcomes and reduce the time and costs associated with drug development, ultimately enhancing the effectiveness of cancer therapies. Their innovative approach positions them at the forefront of cancer research, contributing to the development of more effective and tailored treatment options.